• BTD: Making Sense of M&A, Alliances and Divestments

  • By: Carlos Keener
  • Podcast

BTD: Making Sense of M&A, Alliances and Divestments cover art

BTD: Making Sense of M&A, Alliances and Divestments

By: Carlos Keener
  • Summary

  • BTD is a specialist consultancy that helps people around the world achieve their long-term acquisition, divestment and alliance goals. BTD looks Beyond the Deal, working in partnership with our clients so that they find and complete deals and alliances that build strategic capabilities; ensure that the deals being considered will be successful post-close; deliver the benefits and objectives of their deals quickly, efficiently and cost-effectively, maintain focus on business as usual during and after the deal process and strengthen their own ability to do deals and alliances consistently well in future. Established in 2001, BTD has worked with over 100 clients around the world including Amadeus, Coca-Cola, E.On, GlaxoSmithKline, and Unilever. With offices in London and Boston and an international team, BTD helps leaders reduce deal time and cost, increase deal value, raise capability and maintain a high-performing businesses through the process. Our bespoke services and collaborative approach delivers confidence in the final outcome while ensuring they stay in full control of the process. From pre-deal to post-close – Go Beyond.
    © 2023 BTD: Making Sense of M&A, Alliances and Divestments
    Show More Show Less
Episodes
  • BTD Consulting Alliance Matters Podcast: Cancer Research Horizons - De-Risking Oncology Development
    Jan 31 2023

    One in two people will develop some form of cancer in their lifetimes. Despite decades of work, one-sixth of worldwide deaths are due to cancer. High-stakes research underpinned by strong alliances are making possible new therapies, bringing new hope.

     
    In this podcast, Julie Little (Associate Director of Strategic Alliances) and Steve Wedge (Chief Scientific Officer) of Cancer Research UK discuss their organisation’s major role de-risking oncology research. CRUK has catalysed collaborations including biotech startups and big pharmaceutical companies alike. The newly formed Cancer Research Horizons will supercharge that mission.

     

    BTD’s Nick Palmer leads the discussion. Learn more. Give it a listen.

    #podcast #startups #biotech #research #oncology #pharmaceutical #alliances

     

    Show More Show Less
    35 mins
  • Meet the BTD Team: Mike Princi, Managing Consultant
    Dec 3 2021

    Mike Princi joined the BTD team as a Managing Consultant in 2020 and brings deep experience in advising and leading transformation programmes within complex, international environments. Mike draws upon his military background and eclectic experience as an advisor, owner, operator and investor in business to deliver complex technology programmes and pre and post-merger integration. In this podcast, Mike discusses the principal influences that have guided his career, his passion for coaching and mentoring and his interest in utilising technology to solve business problems. 

    CLICK HERE to follow us on LinkedIn
    www.btd.consulting

    Show More Show Less
    32 mins
  • Meet the BTD Team: Louise Cooper, Managing Consultant
    Oct 25 2021

    A senior project, programme and integration professional, Louise Cooper joined the BTD team several years ago and has supported some of our largest and most complex engagements with clients such as Spectris and Glatfelter. In this podcast, Louise explores the differences between integration and more general transformation programmes, and what she finds challenging and fulfilling in her integration, separation and restructuring work.

    www.btd.consulting
    CLICK HERE to follow us on LinkedIn

    Show More Show Less
    30 mins

What listeners say about BTD: Making Sense of M&A, Alliances and Divestments

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.